2 completed, 1 active not recruiting, 1 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Active not recruiting 1, Unknown 1 |
Follow xiapex: new trials by email Literature Review of xiapex trials Research Report on xiapex
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial Comparing Treatment Strategies in Dupuytren's Contracture Percutaneous needle fasciotomy (PNF), Collagenase Clostridium Histolyticum (CCH) 2.9 MG/ML [Xiaflex], Limited fasciectomy (LF) - Dupuytren Contracture | Phase 4 | Active not recruiting | Tampere University | 302 | 2017-09-15 | 2026-04-29 |
| Prospective Randomized Trial Between Needle Fasciotomy and Xiapex for Dupuytrens Contracture xiapex, percutaneous needle fasciotomy - Dupuytrens Contracture | Phase 4 | Unknown | Oslo University Hospital | 50 | 2015-04-01 | 2015-06-19 |
| Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF Xiapex, Needle aponeurotomy - Dupuytren Contracture | Phase 4 | Completed | University Hospital, Akershus | 80 | 2013-10-01 | 2022-04-26 |
| Retreatment of Recurrent Dupuytren's Contractures Collagenase clostridium histolyticum - Dupuytren's Disease | Phase 4 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 52 | 2012-03-01 | 2017-10-05 |
Dupuytren Contracture (4) · Contracture (2) · Connective Tissue Diseases (1)
Endo USA Inc., a Keenova Therapeutics Company (1) · Oslo University Hospital (1) · Tampere University (1) · University Hospital, Akershus (1)
Norway (2) · Australia (1) · Finland (1) · Sweden (1) · United Kingdom (1) · United States (1)
Aleksi RP Reito, M.D., Ph.D., adjunct professor (1) · Antti OV Malmivaara, M.D., Ph.D., adjunct professor (1) · Hannu Kautiainen, MSc (1) · Per-Henrik Randsborg, PhD (1) · Veronica Urdaneta, MD, MPPH (1)